Zolpidem is intended for short-term use — typically 7 to 10 days, with a maximum of 4 weeks in most clinical guidelines. Longer use increases the risk of tolerance (requiring higher doses for the same effect) and physical or psychological dependence. If your insomnia persists beyond your prescribed course, contact your provider for re-evaluation. They may recommend cognitive behavioral therapy for insomnia (CBT-I), which is considered the first-line long-term treatment for chronic insomnia.

Clinical pharmacokinetic studies found that women clear Zolpidem from their system significantly more slowly than men — resulting in higher blood concentrations the following morning that can impair driving and other tasks requiring alertness. The FDA issued a safety communication recommending that the starting dose for women be lowered to 5 mg for these reasons. Your provider will prescribe the dose most appropriate for your individual profile, including age and any relevant health conditions.

Yes — Zolpidem is a Schedule IV controlled substance with recognized potential for tolerance and dependence, particularly with prolonged or higher-than-prescribed use. This is the primary reason it is prescribed for short-term use only, under active provider supervision. If you have a history of substance use disorder or dependence, disclose this during your medical intake — your provider will factor this into their prescribing decision. Do not take more than prescribed or continue beyond your prescribed course without re-evaluation.

If you wake during the night after taking your dose, do not take a second dose — this significantly increases the risk of morning impairment and complex sleep behaviors. If middle-of-the-night awakening is your primary concern, discuss a lower-dose middle-of-night formulation (such as 1.75 mg for women or 3.5 mg for men) with your provider — these are FDA-approved specifically for this indication and are only appropriate if at least 4 hours remain before your scheduled wake time.

Services are provided by licensed physicians and nurse practitioners via telemedicine in states where permitted, including California, Florida, and others. Telemedicine laws and controlled substance prescribing regulations vary by state — your provider will confirm eligibility during the consultation process. If telemedicine prescribing for a Schedule IV controlled substance is not available in your state, your provider will advise you accordingly and may suggest alternative approaches to managing your insomnia.